Completed PHASE4 INTERVENTIONAL 2-arm NCT02539316

Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population (SMOFPILOT)

Sponsor: Centre Hospitalier Universitaire de Nice

Conditions Dietary and Nutritional Therapies

Updated 6 times since 2017 Last updated: Apr 12, 2017 Started: Jun 30, 2015 Primary completion: Oct 31, 2016 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02539316, this PHASE4 trial focuses on Dietary and Nutritional Therapies and remains completed. Sponsored by Centre Hospitalier Universitaire de Nice, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
May 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Recruiting PHASE4

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Nice

Data source: Centre Hospitalier Universitaire de Nice

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nice, France